Protective effects of nodosin against lipopolysaccharide-induced acute kidney injury through regulation of oxidative stress, inflammation, and ferroptosis in rats
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024
DOI: 10.1007/s00210-024-03148-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Chaojiang Su und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang City, 550001, Guizhou Province, China. Hauptthemen laut MEDLINE: Oxidative Stress, Acute Kidney Injury, Lipopolysaccharides, Ferroptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Research project of Chinese Society of Ethnic Medicine (2021Z1051-451402) supported this study..
Abstract (Originalsprache)
This research aimed to explore the impact of nodosin on lipopolysaccharide (LPS)-induced acute kidney injury (AKI) in rats. The study involved administering nodosin orally at doses of 2 and 4 mg/kg body weight orally to rats for 7 days before induction of AKI. Toward the end of the study, urine, blood, and kidneys were gathered from the rats to undergo biochemical and molecular examination after sacrificing them. Serum Scr, BUN, urine NGAL, and KIM-1 levels were significantly decreased in nodosin-treated AKI rats. Besides, nodosin administration resulted in a significant reduction in kidney MDA and 4-HNE levels. In contrast, antioxidant enzymes such as SOD, CAT, GPx, and GST levels increased, as well as Nrf2, NQO1, and HO-1 levels increased, while Keap-1 mRNA levels decreased in AKI rats. In addition, AKI rats treated with nodosin reversed excessive ferroptosis in the kidneys of LPS-induced AKI rats, as evidenced by increased mRNA and protein levels of GPX4, SLC7A11, and FTH-1. The administration of nodosin significantly reduced levels of inflammatory markers including TLR4, MYD88, NF-κB p65, IkKβ, and IL-1β, while IL-10 levels increased in the AKI-induced rats. Besides, histopathological changes were reduced in AKI-induced rats treated with nodosin. Nodosin proves highly beneficial in safeguarding the kidney from AKI by regulating oxidative stress, inflammation, and ferroptosis. The treatment of AKI could greatly benefit from this option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang City, 550001, Guizhou Province, China.
- Graduate School of Guizhou Medical University, Guiyang City, 550004, Guizhou Province, China.
- Department of Intervention, The Affiliated Hospital of Guizhou Medical University, Guiyang City, 550004, Guizhou Province, China.
- Department of Nephrology, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang City, 550001, Guizhou Province, China. 18985576217jy@sina.com.
Förderung
- Research project of Chinese Society of Ethnic Medicine (2021Z1051-451402) supported this study.
Zitieren
APA
Su, C., Liu, Z., Liu, L., Xiong, Z., Xu, T., Zhang, S., Chen, Y., & Jiang, Y. (2024). Protective effects of nodosin against lipopolysaccharide-induced acute kidney injury through regulation of oxidative stress, inflammation, and ferroptosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03148-x
Vancouver
Su C, Liu Z, Liu L, Xiong Z, Xu T, Zhang S, et al. Protective effects of nodosin against lipopolysaccharide-induced acute kidney injury through regulation of oxidative stress, inflammation, and ferroptosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03148-x
BibTeX
@article{Su2024,
author = {Su, Chaojiang and Liu, Zongyang and Liu, Liting and Xiong, Zhiqian and Xu, Ting and Zhang, Shuai and Chen, Yan and Jiang, Yan},
title = {Protective effects of nodosin against lipopolysaccharide-induced acute kidney injury through regulation of oxidative stress, inflammation, and ferroptosis in rats},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
doi = {10.1007/s00210-024-03148-x}
}
EUVIMED